The independent source for health policy research, polling, and news.
January 23, 2017
In this Wall Street Journal Think Tank column, Drew Altman examines how Republicans would “split the risk pools” between the healthier and the sick in their Affordable Care Act replacement plans, using state high risk pools as a fallback for higher cost patients, and examines the steps that would be necessary to make them effective based on prior experience in the states.
Column Read PostJanuary 10, 2017
As congress prepares to vote on repeal of the Affordable Care Act, Drew Altman discusses whether Republican governors and congressional Republicans will be at odds over key issues when it comes to repealing and replacing the law in this Wall Street Journal Think Tank column.
Column Read PostJanuary 5, 2017
In a New York Times op-ed, Drew Altman draws on observations from focus groups in rust belt states of people in the Affordable Care Act (ACA) marketplaces who voted for President-elect Trump and say they may not like their coverage under the ACA but could like Republican replacement plans even less.
Column Read PostDecember 19, 2016
The 21st Century Cures Act provided a billion dollars in new funding for opioid prevention and treatment. In this Wall Street Journal Think Tank column, Drew Altman looks at the challenges based on a new Kaiser-Washington Post survey of long term opioid users.
Column Read PostDecember 12, 2016
Originally published in The Los Angeles Times, this perspective examines the potential implications for the individual market if key parts of the Affordable Care Act were repealed without a replacement plan.
Column Read PostDecember 9, 2016
In this Wall Street Journal Think Tank column, Drew Altman discusses new data highlighting why pre-exisitng conditions could be a flashpoint issue in the Affordable Care Act repeal and replace debate.
Column Read Post